AlphaHelix Molecular Diagnostics AB (publ) announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced sales was SEK 6.237 million compared to SEK 4.821 million a year ago. Net loss was SEK 246,000 compared to SEK 624,000 a year ago. For the full year, sales was SEK 23.712 million compared to SEK 17.190 million a year ago. Net income was SEK 1.517 million compared to net loss of SEK 983,000 a year ago.